Terapia con cellule staminali and Parkinson’s disease.
La barriera emato-encefalica (BBB) è un bordo semipermeabile altamente selettivo di cellule endoteliali che impedisce molte sostanze, comprese le molecole e le cellule più grandi, dal passaggio dal flusso sanguigno al tessuto cerebrale. This barrier is essential for protecting the brain from toxins and pathogens but can also hinder the delivery of therapeutic agents, comprese le cellule staminali, to the brain.
Stem cells can potentially pass through the blood-brain barrier under certain conditions or with the use of specific delivery methods. Various strategies are being investigated to facilitate stem cell delivery to the brain. Also certain drugs or peptides can temporarily modulate the blood-brain barrier permeability, enabling the passage of therapeutic agents like stem cells.
Cellule staminali, on the other hand, have been reported to bypass the BBB and successfully home to their target in the brain and initiate repair, making them a promising approach in cellular therapy, especially those related to neurodegenerative disease. This review article discusses the mechanism behind the successful homing of stem cells to the brain, their potential role as a drug delivery vehicle, and their applications in neurodegenerative diseases.
Terapia con cellule staminali and Parkinson’s disease.
